. 2021 Aug 5;31(8):464–470. doi: 10.2188/jea.JE20200048

Table 4. Overall incidence of mumps-related complications [95% CI] during the study period in male and female mumps patients in a JMDC database cohort, according to age and sex^a.

Sex	Age group, years old	Mumps-related complication^b

		All complications			Meningitis			Orchitis			Deafness^c			Pancreatitis			Encephalitis			Other complications^d

		Mumps patients, n	Onset patients, n	Incidence [95% CI]	Mumps patients, n	Onset patients, n	Incidence [95% CI]	Mumps patients, n	Onset patients, n	Incidence [95% CI]	Mumps patients, n	Onset patients, n	Incidence [95% CI]	Mumps patients, n	Onset patients, n	Incidence [95% CI]	Mumps patients, n	Onset patients, n	Incidence [95% CI]	Mumps patients, n	Onset patients, n	Incidence [95% CI]
All	All ages	68,280	787	11.5 [10.7–12.4]	68,290	398	5.8 [5.3–6.4]	36,519	242	6.6 [5.8–7.5]	68,137	88	1.3 [1.0–1.6]	68,307	32	0.5 [0.3–0.7]	68,307	22	0.3 [0.2–0.5]	68,307	25	0.4 [0.2–0.5]
	0–5	26,050	132	5.1 [4.2–6.0]	26,050	110	4.2 [3.5–5.1]	14,231	2	0.1 [0.0–0.5]	26,013	7	0.3 [0.1–0.6]	26,056	6	0.2 [0.1–0.5]	26,056	5	0.2 [0.1–0.4]	26,056	2	0.1 [0.0–0.3]
	6–15	35,684	332	9.3 [8.3–10.4]	35,684	227	6.4 [5.6–7.2]	19,036	32	1.7 [1.2–2.4]	35,590	38	1.1 [0.8–1.5]	35,693	13	0.4 [0.2–0.6]	35,693	14	0.4 [0.2–0.7]	35,693	10	0.3 [0.1–0.5]
	16–25	1,529	60	39.2 [30.1–50.2]	1,531	13	8.5 [4.5–14.5]	701	35	49.9 [35.0–68.8]	1,523	8	5.3 [2.3–10.3]	1,531	3	2.0 [0.4–5.7]	1,531	1	0.7 [0.0–3.6]	1,531	3	2.0 [0.4–5.7]
	26–35	2,412	147	60.9 [51.7–71.2]	2,414	26	10.8 [7.0–15.7]	1,158	100	86.4 [70.8–104.0]	2,411	17	7.1 [4.1–11.3]	2,416	5	2.1 [0.7–4.8]	2,416	2	0.8 [0.1–3.0]	2,416	6	2.5 [0.9–5.4]
	36–45	1,898	85	44.8 [35.9–55.1]	1,904	19	10.0 [6.0–15.5]	972	55	56.6 [42.9–73.0]	1,896	8	4.2 [1.8–8.3]	1,904	5	2.6 [0.9–6.1]	1,904	0	0.0 [0.0–1.9]	1,904	3	1.6 [0.3–4.6]
	46–55	549	25	45.5 [29.7–66.5]	549	3	5.5 [1.1–15.9]	345	15	43.5 [24.5–70.7]	546	7	12.8 [5.2–26.2]	549	0	0.0 [0.0–6.7]	549	0	0.0 [0.0–6.7]	549	1	1.8 [0.0–10.1]
	56–64	158	6	38.0 [14.1–80.8]	158	0	0.0 [0.0–23.1]	76	3	39.5 [8.2–111.1]	158	3	19.0 [3.9–54.5]	158	0	0.0 [0.0–23.1]	158	0	0.0 [0.0–23.1]	158	0	0.0 [0.0–23.1]

Male	All ages	36,507	581	15.9 [14.7–17.3]	36,517	260	7.1 [6.3–8.0]	36,519	242	6.6 [5.8–7.5]	36,432	51	1.4 [1.0–1.8]	36,529	21	0.6 [0.4–0.9]	36,529	10	0.3 [0.1–0.5]	36,529	16	0.4 [0.3–0.7]
	0–5	14,228	80	5.6 [4.5–7.0]	14,228	66	4.6 [3.6–5.9]	14,231	2	0.1 [0.0–0.5]	14,206	3	0.2 [0.0–0.6]	14,231	6	0.4 [0.2–0.9]	14,231	1	0.1 [0.0–0.4]	14,231	2	0.1 [0.0–0.5]
	6–15	19,029	227	11.9 [10.4–13.6]	19,029	155	8.1 [6.9–9.5]	19,036	32	1.7 [1.2–2.4]	18,978	22	1.2 [0.7–1.8]	19,036	8	0.4 [0.2–0.8]	19,036	6	0.3 [0.1–0.7]	19,036	6	0.3 [0.1–0.7]
	16–25	701	49	69.9 [52.2–91.4]	703	7	10.0 [4.0–20.4]	701	35	49.9 [35.0–68.8]	697	5	7.2 [2.3–16.7]	703	2	2.8 [0.3–10.2]	703	1	1.4 [0.0–7.9]	703	2	2.8 [0.3–10.2]
	26–35	1,156	124	107.3 [90.0–126.5]	1,158	17	14.7 [8.6–23.4]	1,158	100	86.4 [70.8–104.0]	1,159	7	6.0 [2.4–12.4]	1,160	3	2.6 [0.5–7.5]	1,160	2	1.7 [0.2–6.2]	1,160	4	3.4 [0.9–8.8]
	36–45	972	72	74.1 [58.4–92.4]	978	12	12.3 [6.4–21.3]	972	55	56.6 [42.9–73.0]	974	6	6.2 [2.3–13.4]	978	2	2.0 [0.2–7.4]	978	0	0.0 [0.0–3.8]	978	1	1.0 [0.0–5.7]
	46–55	345	23	66.7 [42.7–98.4]	345	3	8.7 [1.8–25.2]	345	15	43.5 [24.5–70.7]	342	5	14.6 [4.8–33.8]	345	0	0.0 [0.0–10.6]	345	0	0.0 [0.0–10.6]	345	1	2.9 [0.1–16.0]
	56–64	76	6	78.9 [29.5–164.0]	76	0	0.0 [0.0–47.4]	76	3	39.5 [8.2–111.1]	76	3	39.5 [8.2–111.1]	76	0	0.0 [0.0–47.4]	76	0	0.0 [0.0–47.4]	76	0	0.0 [0.0–47.4]

Female	All ages	31,773	206	6.5 [5.6–7.4]	31,773	138	4.3 [3.7–5.1]	na	na	na	31,705	37	1.2 [0.8–1.6]	31,778	11	0.3 [0.2–0.6]	31,778	12	0.4 [0.2–0.7]	31,778	9	0.3 [0.1–0.5]
	0–5	11,822	52	4.4 [3.3–5.8]	11,822	44	3.7 [2.7–5.0]	na	na	na	11,807	4	0.3 [0.1–0.9]	11,825	0	0.0 [0.0–0.3]	11,825	4	0.3 [0.1–0.9]	11,825	0	0.0 [0.0–0.3]
	6–15	16,655	105	6.3 [5.2–7.6]	16,655	72	4.3 [3.4–5.4]	na	na	na	16,612	16	1.0 [0.6–1.6]	16,657	5	0.3 [0.1–0.7]	16,657	8	0.5 [0.2–0.9]	16,657	4	0.2 [0.1–0.6]
	16–25	828	11	13.3 [6.6–23.6]	828	6	7.2 [2.7–15.7]	na	na	na	826	3	3.6 [0.7–10.6]	828	1	1.2 [0.0–6.7]	828	0	0.0 [0.0–4.4]	828	1	1.2 [0.0–6.7]
	26–35	1,256	23	18.3 [11.6–27.4]	1,256	9	7.2 [3.3–13.6]	na	na	na	1,252	10	8.0 [3.8–14.6]	1,256	2	1.6 [0.2–5.7]	1,256	0	0.0 [0.0–2.9]	1,256	2	1.6 [0.2–5.7]
	36–45	926	13	14.0 [7.5–23.9]	926	7	7.6 [3.0–15.5]	na	na	na	922	2	2.2 [0.3–7.8]	926	3	3.2 [0.7–9.4]	926	0	0.0 [0.0–4.0]	926	2	2.2 [0.3–7.8]
	46–55	204	2	9.8 [1.2–35.0]	204	0	0.0 [0.0–17.9]	na	na	na	204	2	9.8 [1.2–35.0]	204	0	0.0 [0.0–17.9]	204	0	0.0 [0.0–17.9]	204	0	0.0 [0.0–17.9]
	56–64	82	0	0.0 [0.0–44.0]	82	0	0.0 [0.0–44.0]	na	na	na	82	0	0.0 [0.0–44.0]	82	0	0.0 [0.0–44.0]	82	0	0.0 [0.0–44.0]	82	0	0.0 [0.0–44.0]

^aBased on health insurance claims data from JMDC Inc.

^bIncidence per 1,000 mumps cases, respectively.

^cDocumented diagnosis of mumps deafness.

^dIncludes: arthritis, myocarditis, nephritis, polyneuropathy, hepatitis, and oophoritis.

na; not analyzable.

Table 4. Overall incidence of mumps-related complications [95% CI] during the study period in male and female mumps patients in a JMDC database cohort, according to age and sexa.

Table 4. Overall incidence of mumps-related complications [95% CI] during the study period in male and female mumps patients in a JMDC database cohort, according to age and sex^a.